Determining the Safety of L-serine in ALS

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety of L-Serine in subjects with Amyotrophic Lateral Sclerosis (ALS) at varied doses.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phoenix Neurological Associates, LTD
• Collaborator: Institute for Ethnomedicine

Criteria

Inclusion Criteria:

1. Age 18-85

2. Male or Female

3. Clinically diagnosed with probable or definite ALS based on El Escorial criteria

4. ALSFRS-R > 25

5. Able to provide informed consent to and comply with all medical procedures

Exclusion Criteria:

1. Outside age range of 18-85

2. Subjects with forced vital capacity (FVC) below 60%

3. Evidence of any motor neuron disease for over 3 years